Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3578)
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
189
Price
$7.10
Total Value
$1.34K
Shares Held After
94,632
% of Holdings
0.2%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,237
Price
$18.61
Total Value
$41.63K
Shares Held After
407,660
% of Holdings
0.5%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,459
Price
$18.61
Total Value
$27.15K
Shares Held After
158,285
% of Holdings
0.9%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,500
Price
$13.59
Total Value
$20.39K
Shares Held After
5,610,702
% of Holdings
0.0%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
6,400
Price
$4.95
Total Value
$31.68K
Shares Held After
389,856
% of Holdings
1.6%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
4,928
Price
$2.67
Total Value
$13.16K
Shares Held After
62,369
% of Holdings
7.3%
MapLight Therapeutics, Inc. (MLPT)
Cox Troy — Director
Shares
15,620
Price
$9.52
Total Value
$148.70K
Shares Held After
15,620
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$532.49
Total Value
$21.30K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
403
Price
$530.97
Total Value
$213.98K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,124
Price
$530.29
Total Value
$596.05K
Shares Held After
324,886
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$529.41
Total Value
$330.88K
Shares Held After
326,010
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,149
Price
$528.20
Total Value
$606.90K
Shares Held After
326,635
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,369
Price
$527.16
Total Value
$721.68K
Shares Held After
327,784
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,473
Price
$526.34
Total Value
$775.29K
Shares Held After
329,153
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$525.02
Total Value
$459.92K
Shares Held After
330,626
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,074
Price
$524.04
Total Value
$562.82K
Shares Held After
331,502
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,367
Price
$523.15
Total Value
$715.15K
Shares Held After
332,576
% of Holdings
0.4%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
200,000
Price
$34.95
Total Value
$6.99M
Shares Held After
1,613,063
% of Holdings
11.0%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
7,798
Price
$5.00
Total Value
$38.99K
Shares Held After
383,456
% of Holdings
2.0%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
688
Price
$87.53
Total Value
$60.22K
Shares Held After
216,438
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Simon Amy — Chief Medical Officer
Shares
16,667
Price
$25.74
Total Value
$429.04K
Shares Held After
85,696
% of Holdings
16.3%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,000
Price
$20.00
Total Value
$20.00K
Shares Held After
51,776
% of Holdings
1.9%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
7
Price
$42.73
Total Value
$299.14
Shares Held After
537,607
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,203
Price
$42.11
Total Value
$92.76K
Shares Held After
537,614
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
5,388
Price
$26.04
Total Value
$140.32K
Shares Held After
3,586,796
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
256,072
Price
$25.50
Total Value
$6.53M
Shares Held After
3,592,184
% of Holdings
6.7%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
1,600
Price
$87.53
Total Value
$140.05K
Shares Held After
167,919
% of Holdings
0.9%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,500
Price
$13.62
Total Value
$20.43K
Shares Held After
5,609,202
% of Holdings
0.0%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
378
Price
$55.91
Total Value
$21.14K
Shares Held After
133,215
% of Holdings
0.3%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
622
Price
$55.54
Total Value
$34.55K
Shares Held After
133,593
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
244
Price
$55.96
Total Value
$13.66K
Shares Held After
133,215
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
756
Price
$55.52
Total Value
$41.97K
Shares Held After
133,459
% of Holdings
0.6%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
4,415
Price
$55.93
Total Value
$246.94K
Shares Held After
453,247
% of Holdings
1.0%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
11,783
Price
$55.52
Total Value
$654.13K
Shares Held After
457,662
% of Holdings
2.5%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.44
Total Value
$17.20K
Shares Held After
652,000
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$535.04
Total Value
$21.40K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
957
Price
$533.53
Total Value
$510.59K
Shares Held After
324,483
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,529
Price
$532.38
Total Value
$814.00K
Shares Held After
325,440
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,836
Price
$531.65
Total Value
$976.11K
Shares Held After
326,969
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,121
Price
$530.49
Total Value
$594.67K
Shares Held After
328,805
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,797
Price
$529.75
Total Value
$951.96K
Shares Held After
329,926
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$528.51
Total Value
$343.53K
Shares Held After
331,723
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
890
Price
$527.14
Total Value
$469.15K
Shares Held After
332,373
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$525.81
Total Value
$357.55K
Shares Held After
333,263
% of Holdings
0.2%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$80.87
Total Value
$606.52K
Shares Held After
377,820
% of Holdings
1.9%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
3,188
Price
$3.37
Total Value
$10.74K
Shares Held After
647,000
% of Holdings
0.5%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
41,319
Price
$9.99
Total Value
$412.78K
Shares Held After
17,283,802
% of Holdings
0.2%
Oric Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
6,100
Price
$12.02
Total Value
$73.32K
Shares Held After
206,672
% of Holdings
2.9%
Oric Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
7,000
Price
$12.02
Total Value
$84.14K
Shares Held After
38,300
% of Holdings
15.5%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
12,500
Price
$11.71
Total Value
$146.43K
Shares Held After
702,770
% of Holdings
1.7%
Showing 51–100 of 3578 transactions (page 2 of 72)